FGF-23 is a biomarker of RV dysfunction and congestion in patients with HFrEF

There is no biomarker reflecting right ventricular dysfunction in HFrEF patients used in clinical practice. We have aimed to look for a circulating marker of RV dysfunction employing a quantitative proteomic strategy. The Olink Proteomics Multiplex panels (Cardiovascular Disease II, III, Cardiometab...

Descripción completa

Detalles Bibliográficos
Autores principales: Benes, Jan, Kroupova, Katerina, Kotrc, Martin, Petrak, Jiri, Jarolim, Petr, Novosadova, Vendula, Kautzner, Josef, Melenovsky, Vojtech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520041/
https://www.ncbi.nlm.nih.gov/pubmed/37749114
http://dx.doi.org/10.1038/s41598-023-42558-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520041/
https://www.ncbi.nlm.nih.gov/pubmed/37749114
http://dx.doi.org/10.1038/s41598-023-42558-4

Ejemplares similares